PT  - JOURNAL ARTICLE
AU  - Dale Guenter
AU  - Jose Esparza
AU  - Ruth Macklin
TI  - Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS)
AID  - 10.1136/jme.26.1.37
DP  - 2000 Feb 01
TA  - Journal of Medical Ethics
PG  - 37--43
VI  - 26
IP  - 1
4099  - http://jme.bmj.com/content/26/1/37.short
4100  - http://jme.bmj.com/content/26/1/37.full
SO  - J Med Ethics2000 Feb 01; 26
AB  - Research that is initiated, designed or funded by sponsor agencies based in countries with relatively high social and economic development, and conducted in countries that are relatively less developed, gives rise to many important ethical challenges. Although clinical trials of HIV vaccines began ten years ago in the US and Europe, an increasing number of trials are now being conducted or planned in other countries, including several that are considered “developing” countries. Safeguarding the rights and welfare of individuals participating as research subjects in developing countries is a priority. In September, 1997, the Joint United Nations Programme on HIV/AIDS (UNAIDS) embarked on a process of international consultation; its purpose was further to define the important ethical issues and to formulate guidance that might facilitate the ethical design and conduct of HIV vaccine trials in international contexts. This paper summarises the major outcomes of the UNAIDS consultative process.